|
1
|
Sudo D, Monobe Y, Yashiro M, Mieno NM,
Uehara R, Tsuchiya K, Tsuchiya K, Sonobe T and Nakamura Y: Coronary
artery lesions of incomplete Kawasaki disease: A nationwide survey
in Japan. Eur J Pediatr. 171:651–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fukazawa R: Long-term prognosis of
Kawasaki disease: Increased cardiovascular risk? Curr Opin Pediatr.
22:587–592. 2010.PubMed/NCBI
|
|
3
|
Tsuda E, Abe T and Tamaki W: Acute
coronary syndrome in adult patients with coronary artery lesions
caused by Kawasaki disease: Review of case reports. Cardiol Young.
21:74–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Makino N, Nakamura Y, Yashiro M, Ae R,
Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K and Yanagawa H:
Descriptive epidemiology of Kawasaki disease in Japan, 2011 2012:
From the results of the 22nd nationwide survey. J Epidemiol.
25:239–245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Del Principe D, Pietraforte D, Gambardella
L, Marchesi A, de Jacobis Tarissi I, Villani A, Malorni W and
Straface E: Pathogenetic determinants in Kawasaki disease: The
haematological point of view. J Cell Mol Med. 21:632–639. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shulman ST and Rowley AH: Kawasaki
disease: Insights into pathogenesis and approaches to treatment.
Nat Rev Rheumatol. 11:475–482. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoon KL: Update of genetic susceptibility
in patients with Kawasaki disease. Korean J Pediatr. 58:84–88.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sunderland N, Skroblin P, Barwari T,
Huntley RP, Lu R, Joshi A, Lovering RC and Mayr M: MicroRNA
biomarkers and platelet reactivity: The clot thickens. Circ Res.
120:418–435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Song Y, Yao L, Song G and Teng C:
Circulating microRNAs: Promising biomarkers involved in several
cancers and other diseases. DNA Cell Biol. 36:77–94. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tijsen AJ, Pinto YM and Creemers EE:
Circulating microRNAs as diagnostic biomarkers for cardiovascular
diseases. Am J Physiol Heart Circ Physiol. 303:H1085–H1095. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Rooij E and Olson EN: MicroRNA:
Powerful new regulators of heart disease and provocative
therapeutic targets. J Clin Invest. 117:2369–2376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'Connell RM, Taganov KD, Boldin MP, Cheng
G and Baltimore D: MicroRNA-155 is induced during the macrophage
inflammatory response. Proc Natl Acad Sci USA. 104:1604–1609. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reid G, Kirschner MB and van Zandwijk N:
Circulating microRNAs: Association with disease and potential use
as biomarkers. Crit Rev Oncol Hematol. 80:193–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He
J, Qin YW and Jing Q: Circulating microRNA: A novel potential
biomarker for early diagnosis of acute myocardial infarction in
humans. Eur Heart J. 31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ji X, Takahashi R, Hiura Y, Hirokawa G,
Fukushima Y and Iwai N: Plasma miR-208 as a biomarker of myocardial
injury. Clin Chem. 55:1944–1949. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akbas F, Coskunpinar E, Aynaci E, Oltulu Y
and Yildiz P: Analysis of serum micro-RNAs as potential biomarker
in chronic obstructive pulmonary disease. Exp Lung Res. 38:286–294.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Newburger JW, Takahashi M, Gerber MA,
Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P,
Baltimore RS, et al: Diagnosis, treatment, and long-term management
of Kawasaki disease: A statement for health professionals from the
committee on rheumatic fever, endocarditis, and Kawasaki disease,
council on cardiovascular disease in the young, American heart
association. Circulation. 110:2747–2771. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sheikh Ali MS, Xia K, Li F, Deng X, Salma
U, Deng H, Wei Wei L, Yang TL and Peng J: Circulating miR-765 and
miR-149: Potential noninvasive diagnostic biomarkers for geriatric
coronary artery disease patients. Biomed Res Int.
2015:7403012015.PubMed/NCBI
|
|
23
|
Tömböl Z, Eder K, Kovács A, Szabó PM,
Kulka J, Likó I, Zalatnai A, Rácz G, Tóth M, Patócs A, et al:
MicroRNA expression profiling in benign (sporadic and hereditary)
and recurring adrenal pheochromocytomas. Mod Pathol. 23:1583–1595.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu N, Li Z, Yu Z, Yan F, Liu Y, Lu X and
Yang W: MicroRNA-33b suppresses migration and invasion by targeting
c-Myc in osteosarcoma cells. PLoS One. 9:e1153002014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu H and Leung SW: Identification of
microRNA biomarkers in type 2 diabetes: A meta-analysis of
controlled profiling studies. Diabetologia. 58:900–911. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Orenstein JM, Shulman ST, Fox LM, Baker
SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarévian JP,
Perlman EJ, et al: Three linked vasculopathic processes
characterize Kawasaki disease: A light and transmission electron
microscopic study. PLoS One. 7:e389982012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shimizu C, Kim J, Stepanowsky P, Trinh C,
Lau HD, Akers JC, Chen C, Kanegaye JT, Tremoulet A, Ohno-Machado L
and Burns JC: Differential expression of miR-145 in children with
Kawasaki disease. PLoS One. 8:e581592013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2015. View Article : Google Scholar
|
|
29
|
Fichtlscherer S, Zeiher AM and Dimmeler S:
Circulating microRNAs: Biomarkers or mediators of cardiovascular
diseases? Arterioscler Thromb Vasc Biol. 31:2383–2390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gilad S, Meiri E, Yogev Y, Yogev Y,
Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M,
Cholakh H, et al: Serum microRNAs are promising novel biomarkers.
PLoS One. 3:e31482008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yun KW, Lee JY, Yun SW, Lim IS and Choi
ES: Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p
in children with Kawasaki disease. Pediatr Cardiol. 35:745–752.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saito K, Nakaoka H, Takasaki I, Hirono K,
Yamamoto S, Kinoshita K, Miyao N, Ibuki K, Ozawa S, Watanabe K, et
al: MicroRNA-93 may control vascular endothelial growth factor A in
circulating peripheral blood mononuclear cells in acute Kawasaki
disease. Pediatr Res. 80:425–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rong X, Jia L, Hong L, Pan L, Xue X, Zhang
C, Lu J, Jin Z, Qiu H, Wu R and Chu M: Serum miR-92a-3p as a new
potential biomarker for diagnosis of Kawasaki disease with coronary
artery lesions. J Cardiovasc Transl Res. 10:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rowley AH, Pink AJ, Reindel R, Innocentini
N, Baker SC, Shulman ST and Kim KY: A study of cardiovascular miRNA
biomarkers for Kawasaki disease. Pediatr Infect Dis J.
33:1296–1299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He M, Chen Z, Martin M, Zhang J, Sangwung
P, Woo B, Tremoulet AH, Shimizu C, Jain MK, Burns JC and Shyy JY:
miR-483 Targeting of CTGF suppresses endothelial-to-mesenchymal
transition: Therapeutic implications in Kawasaki disease. Circ Res.
120:354–365. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Johnnidis JB, Harris MH, Wheeler RT,
Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD and
Camargo FD: Regulation of progenitor cell proliferation and
granulocyte function by microRNA-223. Nature. 451:1125–1129. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vickers KC, Palmisano BT, Shoucri BM,
Shamburek RD and Remaley AT: MicroRNAs are transported in plasma
and delivered to recipient cells by high-density lipoproteins. Nat
Cell Biol. 13:423–433. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tabet F, Vickers KC, Torres Cuesta LF,
Wiese CB, Shoucri BM, Lambert G, Catherinet C, Prado-Lourenco L,
Levin MG, Thacker S, et al: HDL-transferred microRNA-223 regulates
ICAM-1 expression in endothelial cells. Nat Commun. 5:32922014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thum T: MicroRNA-223 made its way into
vascular research. Circ Res. 113:1270–1271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan Y, Liang H, Liu H, Li D, Chen X, Li L,
Zhang CY and Zen K: Platelet-secreted microRNA-223 promotes
endothelial cell apoptosis induced by advanced glycation end
products via targeting the insulin-like growth factor 1 receptor. J
Immunol. 192:437–446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chu M, Wu R, Qin S, Hua W, Shan Z, Rong X,
Zeng J, Hong L, Sun Y, Liu Y, et al: Bone marrow-derived
microRNA-223 works as an endocrine genetic signal in vascular
endothelial cells and participates in vascular injury from Kawasaki
disease. J Am Heart Assoc. 6:pii: e004878. 2017. View Article : Google Scholar
|
